Share on StockTwits

OraSure Technologies Inc. (NASDAQ:OSUR) updated its second quarter earnings guidance on Wednesday. The company provided earnings per share guidance of ($0.10)-($0.09) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.08), AR Network reports. The company issued revenue guidance of $25.2-25.7 million, compared to the consensus revenue estimate of $25.12 million.

A number of analysts have recently weighed in on OSUR shares. Analysts at Cowen and Company raised their price target on shares of OraSure Technologies from $8.00 to $9.00 in a research note on Friday, May 2nd. On a related note, analysts at TheStreet upgraded shares of OraSure Technologies from a sell rating to a hold rating in a research note on Monday, March 17th. Finally, analysts at Raymond James raised their price target on shares of OraSure Technologies from $7.50 to $10.00 in a research note on Thursday, March 6th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus price target of $8.72.

Shares of OraSure Technologies Inc. (NASDAQ:OSUR) traded down 0.75% on Wednesday, hitting $6.59. 570,905 shares of the company’s stock traded hands. OraSure Technologies Inc. has a 1-year low of $3.75 and a 1-year high of $8.60. The stock has a 50-day moving average of $7.15 and a 200-day moving average of $6.71. The company’s market cap is $367.9 million.

OraSure Technologies (NASDAQ:OSUR) last announced its earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.13) by $0.03. The company had revenue of $23.50 million for the quarter, compared to the consensus estimate of $23.28 million. During the same quarter last year, the company posted ($0.18) earnings per share. OraSure Technologies’s revenue was up 10.8% compared to the same quarter last year. Analysts expect that OraSure Technologies Inc. will post $-0.35 EPS for the current fiscal year.

OraSure Technologies, Inc, is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using the Company’s oral fluid technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.